COVID-19 pandemic and lockdown stress consequences in people with and without Irritable Bowel Syndrome.
COVID-19
Irritable bowel syndrome
Pandemic
Quality of life
Stress
Journal
Ethics, medicine, and public health
ISSN: 2352-5525
Titre abrégé: Ethics Med Public Health
Pays: France
ID NLM: 101681177
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
04
01
2021
accepted:
21
03
2021
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
While all resources have been mobilized to fight COVID-19, this study aimed to analyze the consequences of lockdown and pandemic stress in participants with and without Irritable Bowel Syndrome (IBS). An online survey was proposed to people with or without IBS during the exponential phase of the pandemic in France. The questionnaire included questions about socio-demographic data, conditions of confinement, activities carried out, IBS characteristics, measurement of stress level, consequences on sleep, fatigue, anxiety and depression, and quality of life (both perceived non-specific and specific for IBS). From March 31 to April 15, 2020, 304 participants, 232 with IBS and 72 without were included in the survey (mean age: 46.8 ± 16.8 years, female gender: 75.3%). Age, level of education, financial resources, living space per person and activities performed during confinement were identical in both groups. Stress linked to fear of COVID-19, lockdown and financial worries was at the same level in both groups, but the psychological consequences and deterioration of quality of life (QOL) were both higher in IBS participants. In a univariate analysis, teleworking, solitary confinement, and low household resources had a variable impact on the scores of depression, anxiety, fatigue and non-specific perceived QOL, but in a multivariate analysis, the only factor explaining a deterioration of non-specific QOL was the fact of suffering from IBS. Stress linked to the COVID-19 pandemic and confinement is high and equivalent in both IBS and non-IBS participants, with higher psychological and QOL consequences in IBS patients who have altered coping capacities.
Sections du résumé
BACKGROUND
BACKGROUND
While all resources have been mobilized to fight COVID-19, this study aimed to analyze the consequences of lockdown and pandemic stress in participants with and without Irritable Bowel Syndrome (IBS).
METHODOLOGY
METHODS
An online survey was proposed to people with or without IBS during the exponential phase of the pandemic in France. The questionnaire included questions about socio-demographic data, conditions of confinement, activities carried out, IBS characteristics, measurement of stress level, consequences on sleep, fatigue, anxiety and depression, and quality of life (both perceived non-specific and specific for IBS).
RESULTS/DISCUSSION
CONCLUSIONS
From March 31 to April 15, 2020, 304 participants, 232 with IBS and 72 without were included in the survey (mean age: 46.8 ± 16.8 years, female gender: 75.3%). Age, level of education, financial resources, living space per person and activities performed during confinement were identical in both groups. Stress linked to fear of COVID-19, lockdown and financial worries was at the same level in both groups, but the psychological consequences and deterioration of quality of life (QOL) were both higher in IBS participants. In a univariate analysis, teleworking, solitary confinement, and low household resources had a variable impact on the scores of depression, anxiety, fatigue and non-specific perceived QOL, but in a multivariate analysis, the only factor explaining a deterioration of non-specific QOL was the fact of suffering from IBS.
CONCLUSION/PERSPECTIVES
UNASSIGNED
Stress linked to the COVID-19 pandemic and confinement is high and equivalent in both IBS and non-IBS participants, with higher psychological and QOL consequences in IBS patients who have altered coping capacities.
Identifiants
pubmed: 34150971
doi: 10.1016/j.jemep.2021.100660
pii: S2352-5525(21)00037-2
pmc: PMC8206631
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100660Informations de copyright
© 2021 Elsevier Masson SAS. All rights reserved.
Références
Aliment Pharmacol Ther. 2016 Aug;44(3):246-58
pubmed: 27240555
Psychiatry Res. 2020 May;287:112921
pubmed: 32240896
J Occup Health Psychol. 2002 Oct;7(4):354-64
pubmed: 12396068
Ethics Med Public Health. 2020 Oct-Dec;15:100571
pubmed: 32838000
BMC Public Health. 2013 Dec 03;13:1116
pubmed: 24299568
Asian J Psychiatr. 2020 Jun;51:102081
pubmed: 32289729
Psychiatry Res. 2020 Jun;288:112958
pubmed: 32283450
Br J Health Psychol. 2014 Sep;19(3):592-605
pubmed: 23834735
J Sleep Res. 2020 Aug;29(4):e13052
pubmed: 32246787
BMC Gastroenterol. 2019 Jun 27;19(1):111
pubmed: 31248366
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402
pubmed: 9146781
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076
Clin Res Hepatol Gastroenterol. 2020 Nov;44(6):961-967
pubmed: 32205115
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
N Engl J Med. 2020 Apr 30;382(18):e40
pubmed: 32227759
J Appl Psychol. 2008 Nov;93(6):1412-21
pubmed: 19025257
Neurogastroenterol Motil. 2015 Jun;27(6):796-804
pubmed: 25817301
Dig Dis Sci. 1998 Feb;43(2):400-11
pubmed: 9512138
Int J Ment Health Nurs. 2019 Feb;28(1):54-70
pubmed: 30232822
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
Med Sci Monit. 2020 Mar 20;26:e923921
pubmed: 32194290
Int J Prev Med. 2019 May 17;10:72
pubmed: 31198507
J Law Med Ethics. 2012 Fall;40(3):630-54
pubmed: 23061590
Ethics Med Public Health. 2021 Mar;16:100605
pubmed: 33078131
J Gen Intern Med. 2020 Aug;35(8):2296-2303
pubmed: 32472486
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1565-1571.e3
pubmed: 28286196
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Gastroenterology. 2000 Sep;119(3):654-60
pubmed: 10982758
Clin Epidemiol. 2014 Feb 04;6:71-80
pubmed: 24523597
Eur Neuropsychopharmacol. 2020 Jun;35:12-16
pubmed: 32446705
N Engl J Med. 2017 Jun 29;376(26):2566-2578
pubmed: 28657875
Gut. 1998 Aug;43(2):256-61
pubmed: 10189854
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Gastroenterol Res Pract. 2012;2012:157340
pubmed: 22190912
Br J Health Psychol. 2012 Feb;17(1):44-59
pubmed: 22233104
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
BMJ. 2015 Nov 26;351:h6161
pubmed: 26611143
Neurogastroenterol Motil. 2010 Aug;22(8):893-900
pubmed: 20465594